Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) EBIT Margin (2016 - 2025)

Bio Key International's EBIT Margin history spans 16 years, with the latest figure at 57.57% for Q3 2025.

  • For Q3 2025, EBIT Margin fell 3051.0% year-over-year to 57.57%; the TTM value through Sep 2025 reached 61.5%, up 1347.0%, while the annual FY2024 figure was 57.88%, 5593.0% up from the prior year.
  • EBIT Margin for Q3 2025 was 57.57% at Bio Key International, up from 63.87% in the prior quarter.
  • Across five years, EBIT Margin topped out at 4.96% in Q2 2021 and bottomed at 284.13% in Q4 2022.
  • The 5-year median for EBIT Margin is 76.53% (2021), against an average of 92.95%.
  • The largest annual shift saw EBIT Margin soared 34813bps in 2021 before it plummeted -9532bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 213.85% in 2021, then tumbled by -33bps to 284.13% in 2022, then soared by 47bps to 149.24% in 2023, then skyrocketed by 42bps to 86.69% in 2024, then surged by 34bps to 57.57% in 2025.
  • Per Business Quant, the three most recent readings for BKYI's EBIT Margin are 57.57% (Q3 2025), 63.87% (Q2 2025), and 39.86% (Q1 2025).